A History Lesson in Insurance Screening

George, Hank
September 2008
Best's Review;Sep2008, Vol. 109 Issue 5, p60
Trade Publication
The author reflects on the hypothetical consequence of the proposed cancer marker carcinoembryonic antigen (CEA) for screening insurance applicants in the U.S. He stated that CEA must not be used since it has not been approved and can never be approved as a screening test. He added that the majority who are pinpointed by means of an abnormal CEA test will be told that they are cancer-free.


Related Articles

  • KOC is a novel molecular indicator of malignancy. Mueller, F; Bommer, M; Lacher, U; Ruhland, C; Stagge, V; Adler, G; Gress, T M; Seufferlein, T // British Journal of Cancer;3/10/2003, Vol. 88 Issue 5, p699 

    The detection of malignant cells in fine-needle aspirates (FNA's) using marker genes is hampered by the fact that these markers are only expressed by certain malignancies or lack sensitivity and/or specificity. Here we report the results of a prospective pilot study examining the expression of...

  • Carcinoembryonic Antigen - A Paradoxical Risk Selection Tool for Insurers. MacKenzie, Ross // Journal of Insurance Medicine;2007, Vol. 39 Issue 4, p259 

    The article looks at the use of tumor marker testing in the life insurance industry. A study which tracked individuals tested for tumor markers through the National Death Index to determine mortality risks is discussed. Screening life insurance applicants for carcinoembryonic antigen (CEA) is...

  • The relationship of serum CEA and CA 19-9 levels to liver metastasis and pancreatic invasion in esophageal cancer. Türkyilmaz, Atila; Eroğlu, Atilla; Aydin, Yener; Karaoğlanoğlu, Nurettin // Turkish Journal of Medical Sciences;2009, Vol. 39 Issue 6, p895 

    Aim: Previous studies have examined levels of CEA and CA 19-9 in esophageal cancer patients, but have not determined a significant relationship between CEA and CA 19-9 levels and liver metastasis and pancreatic invasion in patients with esophageal cancer. In this study, we compared the serum...

  • Tumour biomarkers in heart failure: is there a role for CA-125? Yilmaz, Mehmet Birhan; Nikolaou, Maria; Cohen Solal, Alain // European Journal of Heart Failure;Jun2011, Vol. 13 Issue 6, p579 

    Tumour markers are used for the screening, diagnosis, and stratification of cancer disease. Recently, the potential role of some tumour markers has also been explored in the context of heart failure. These include CA-125, CA 15-3, CA 19-9, carcinoembryonic antigen, alpha-feto protein, tissue...

  • CA 15-3 and CEA: Not So Novel, But Useful Breast Cancer Tumor Markers. Ershler, William B. // Clinical Oncology Alert;May2008, Vol. 24 Issue 5, p37 

    There remains uncertainty on the overall value of circulating tumor markers in the management of breast cancer. To address this, Park and colleagues from Yonsei University Medical College in Seoul, South Korea examined the association between certain tumor markers [cancer antigen 15-3 (CA 15-3)...

  • Diagnostic Value of CEA in Pleural Fluid for Differential Diagnosis of Benign and Malign Pleural Effusion. Radienovic-Petkovic, Tatjana; Pejcic, Tatjana; Nastasijević-Borovac, Desa; Rancic, Milan; Radojkovic, Danijela; Radojkovic, Milan; Djordjevic, Ivanka // Medicinski Arhiv;2009, Vol. 63 Issue 3, p141 

    The diagnostic value of tumor markers in pleural fluid is still the subject of debate. The aim of this work was to evaluate diagnostic value of carcinoembryonic antigen (CEA) in pleural fluid for differentiating malignant from non malign pleural effusion, and their additive value to cytological...

  • The Prognostic Value of Preoperative Serum Levels of CEA and CA19-9 in Patients with Gastric Cancer. Kodera, Yasuhira; Yamamura, Yohitaka; Torii, Akihito; Uesaka, Katsuhiko; Hirai, Takashi; Yasui, Kenzo; Morimoto, Takeshi; Kato, Tomoyuki; Kito, Tsuyoshi // American Journal of Gastroenterology;Jan1996, Vol. 91 Issue 1, p49 

    Objectives: The clinical significance of preoperative serum levels of tumor markers CEA and CA19-9 was evaluated in gastric cancer patients. Methods: Serum levels of CEA and CA19-9 were measured in 663 patients with gastric cancer who underwent laparotomies over a recent 4-yr period (1990-1993)....

  • © A COMPARISON OF THE PHYSICOCHEMICAL PROPERTIES OF CARCINOEMBRYONIC ANTIGEN IN EXTRACTS OF TUMOUR TISSUE, ASCITIC AND CYST FLUID FROM OVARIAN CANCER. Hill, R.; Daunter, B.; Magon, H.; Khoo, S.K.; Mackay, E.V. // Australian Journal of Experimental Biology & Medical Science;Aug1981, Vol. 59 Issue 4, p469 

    Compares the properties of ovarian carcinoembryonic antigen (CEA) obtained from extracts of ovarian tumor tissue, ascitic fluid and cyst fluid. Indications that the ovarian CEA possesses similar properties to those of colonic CEA; Isoelectric point of CEA from tumor tissue and cyst fluid...

  • 99mTc-Labeled Nanobodies: A New Type of Targeted Probes for Imaging Antigen Expression. Cortez-Retamozo, Virna; Lahoutte, Tony; Caveliers, Vicky; Tchouate Gainkam, Lea Olive; Hernot, Sophie; Packeu, Ann; De Vos, Filip; Vanhove, Chris; Muyldermans, Serge; De Baetselier, Patrick; Revets, Hilde // Current Radiopharmaceuticals;Jan2008, Vol. 1 Issue 1, p37 

    Introduction: The development of specific radiolabeled probes towards molecular markers in vivo has gained interest as targeted imaging allows for a more accurate detection of diseases. We investigate the feasibility of targeted imaging of cancer antigens using the variable domain of single...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics